Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Sell
117
-15
-11% -$1.37K ﹤0.01% 274
2026
Q1
$13.6K Hold
132
0.01% 223
2025
Q4
$16.5K Sell
132
-5
-4% -$637 0.01% 213
2025
Q3
$18.4K Sell
137
-401
-75% -$52.6K 0.01% 232
2025
Q2
$73.2K Buy
538
+401
+293% +$52.9K 0.04% 128
2025
Q1
$18.2K Buy
137
+5
+4% +$636 0.01% 204
2024
Q4
$14.9K Sell
132
-2
-1% -$231 0.01% 238
2024
Q3
$15.3K Hold
134
0.01% 221
2024
Q2
$13.9K Buy
134
+4
+3% +$424 0.01% 226
2024
Q1
$14.8K Hold
130
0.01% 219
2023
Q4
$14.3K Buy
+130
New +$13K 0.01% 208

Other funds holding ABT

Aspect Partners's ABT Position: Q2 2026 in Review

Aspect Partners reduced its Abbott (ABT) stake by 11% in Q2 2026, selling an estimated $1.37K and leaving 117 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

Aspect Partners first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $73.2K in Q2 2025. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Aspect Partners held 117 shares of Abbott worth $10.6K as of Q2 2026.
  • Aspect Partners sold 15 Abbott shares in Q2 2026, an estimated $1.37K.
  • Abbott made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #274 holding.
  • Aspect Partners first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's Abbott position peaked at $73.2K in Q2 2025.
  • 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.